Condition
Schizoaffecitve Disorder clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Schizoaffecitve Disorder clinical trials that are recruiting, at sites in 3 countries (most in United States (3), Israel (1), South Korea (1)). By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Schizoaffecitve Disorder clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combination of Deferiprone and N-Acetylcysteine for Negative Symptoms in Schizophrenia | Phase 2 | Jerusalem and 1 other locations | Recruiting | Aug 12, 2026 |
| Digital Therapeutics for Social Cognition in Schizophrenia Spectrum Disorder | — | Seoul | Recruiting | Aug 10, 2026 |
| Gamma brain-feedback to boost working memory in schizophrenia | Phase 2 | La Jolla, California | Recruiting | May 18, 2026 |
| Virtual reality mindfulness for reducing aggression in schizophrenia | — | New York, New York and 1 other locations | Recruiting | Feb 25, 2026 |
| Cobenfy in Schizophrenia: testing dopamine transmission with PET/MRI | Phase 1/2 | New York, New York | Recruiting | Feb 20, 2026 |
All recruiting trials (5)
-
Combination of Deferiprone and N-Acetylcysteine for Negative Symptoms in Schizophrenia
This study tests whether adding deferiprone and NAC to the usual antipsychotic treatment can help people with schizophrenia or schizoaffective disorder who have prominent negative symptoms.
-
Digital Therapeutics for Social Cognition in Schizophrenia Spectrum Disorder
A smartphone-based digital therapy called AffectUs is being tested to see if it can help people with schizophrenia or schizoaffective disorder improve social cognition, alongside their usual treatment.
-
Gamma brain-feedback to boost working memory in schizophrenia
This trial tests whether real-time gamma EEG neurofeedback helps people with schizophrenia or schizoaffective disorder improve working memory.
-
Virtual reality mindfulness for reducing aggression in schizophrenia
We will test whether a virtual reality mindfulness program can help people with schizophrenia or schizoaffective disorder reduce impulsive aggression.
-
Cobenfy in Schizophrenia: testing dopamine transmission with PET/MRI
This small, early-stage trial tests three doses of Cobenfy in people with schizophrenia to see if it changes dopamine activity in the brain using PET imaging.
Related topics
Quick answers
How many Schizoaffecitve Disorder clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Israel (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.